Cassava sciences invited to present in four upcoming investor conferences

Austin, texas, sept. 06, 2023 (globe newswire) -- cassava sciences, inc. (nasdaq: sava), a biotechnology company committed to the treatment of alzheimer's disease dementia, today announced that it has been invited to present at the following investor conferences.
SAVA Ratings Summary
SAVA Quant Ranking